Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
cancer drugs
4
×
clinical trials
ipo
4
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
sanofi
amgen
deals
fda
investing
new york blog main
new york top stories
revolution medicines
san francisco
schrödinger
takeda pharmaceutical
the column group
third rock ventures
warp drive bio
adaptive biotechnologies
agios pharmaceuticals
alector
allergan
apollomics
bernie sanders
beta bionics
bill & melinda gates foundation trust
black diamond therapeutics
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
civica rx
cobimetinib
What
cancer
ipo
medicines
pharmaceutical
proteins
research
revolution
appetite
bio
black
bread
butter
buyout
cancer’s
cash
company’s
course
despite
development
diabetes
diamond’s
discover
disease
drug
drugs
eli
experimental
family
frontiers
giant
grabbed
growing
handiwork
hardest
hasn’t
helped
hit
hold
hottest
hunters
Language
unset
Current search:
ipo
×
" cancer drugs "
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More